Synonyms: AM-80 | AM80 | Amnolake® | retinobenzoic acid
tamibarotene is an approved drug
Compound class:
Synthetic organic
Comment: This compound is a retinoic acid receptor α (RARα) agonist [3].
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
No information available. |
Summary of Clinical Use |
Approved in Japan for the treatment of acute promyelocytic leukemia, tamibarotene was withdrawn in Europe for this use in 2009. ClinicalTrials.gov has several records for clinical trials involving tamibarotene- click here to access these records. |
Mechanism Of Action and Pharmacodynamic Effects |
Agonist for retinoic acid alpha and beta receptors. |